Summary
Evidence to support many blood transfusion policies and practices in sub-Saharan Africa (SSA) is weak or lacking. SSA cannot extrapolate from wealthy countries' research findings because its environment, users and structures are very different and SSA has critical blood shortages. SSA needs to generate its own evidence but research funds are very scarce and need to be carefully targeted to match need. This study aimed to define this need by determining research priorities for blood services in SSA. Thirty-five stakeholders representing diverse blood services' interests and expertise participated in a workshop. An adapted 'consensus development method' was used to identify, agree and justify research priorities under five themes through small group and plenary discussion, and cumulative voting. Research priorities covered traditional research areas, such as clinical use of blood and infection screening, but also highlighted many new, underresearched topics, mostly concerning blood service 'systems', such as economics, blood components and regulation. Lack of electronic information management systems was an important hindrance to the blood services' ability to generate robust research data. This study has identified and prioritised novel research that will help blood services in SSA to address their own needs including their most urgent problem: the lack of access to adequate blood supplies. To catalyse this research blood services in SSA need to enhance their capacity to conduct, commission and manage research and to strengthen their collaborations within and beyond Africa.
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The World Health Organization (WHO) has set out global standards for blood transfusion services (WHO, 2016) . These state that there should be universal access to safe and effective blood and blood products for transfusion, which should be used appropriately, and that blood donor and patient safety should be ensured. To achieve universal access, there must be enough blood available to meet the needs of the population and it must be accessible to those who need it. WHO has been committed to these standards for 40 years and although there have been major improvements in blood safety in sub-Saharan Africa (SSA), driven largely by the human immunodeficiency virus (HIV) epidemic, progress in achieving standards relating to adequate supplies and universal access, has been disappointing.
WHO recommends a clear process for producing guidelines and recommendations (WHO, 2012) . Some international transfusion guidelines, particularly those relating to reducing HIV infection risk, are based on published evidence, but, for others (for example recommended targets for units collected/ 1000 population), evidence is lacking. Policy makers and national blood services need to understand how recommendations have been derived and the strength of evidence that supports them. This information informs transfusion research at national level so that international guidelines can be adapted to the national context and solutions found to local problems.
Despite a 25% increase in the global number of blood donations from 2004 to 2014, lethal blood shortages are still widespread across Africa (Dzik, 2015; WHO, 2015a) . For example, a review found that 26% of women with obstetric haemorrhage in Africa who reached hospital died because there was no blood available . Mortality among children with severe anaemia who wait more than 8 h for a transfusion is 52%; 90% of deaths occurred within 2Á5 h of arrival in hospital (Kiguli et al, 2014) . The ongoing serious blood shortages indicate that current strategies to provide adequate blood for transfusion in SSA are not working. Research on how to increase donations and reduce wastage within blood banks and hospitals is urgently needed to identify novel and context-specific solutions to the problem of blood shortages. Improving blood supplies involves motivating new donors and retaining existing donors, maximising the sensitivity of infection screening while simultaneously minimising discards through false positivity, efficient stock management to optimise storage and transport and minimise outdating, and appropriate clinical use of blood.
Many high-income countries have achieved sufficiency of blood supplies by centralising collection, testing and distribution, using electronic records to register and recall donors, and through electronic tracking of blood from donor to recipient. Sophisticated haemovigilance systems, hospital transfusion committees and specialised practitioners to oversee appropriate clinical use of blood have also contributed. For poorer countries in SSA these approaches may not be feasible, affordable or even appropriate because the context and pattern of blood donations and usage in SSA is very different from more wealthy regions. In SSA around 75% of blood is used by children and pregnant women for emergencies whereas 76% of blood in high-income countries is used electively in patients over 65 years mostly for oncology and surgery (WHO, 2015a) . A substantial proportion of blood in SSA is transfused as whole blood whereas in high-income countries whole blood is processed into red cells, plasma and other components and products (Loua, 2016) . At least a third of donors in SSA are family members so blood is often donated and used within a hospital (Loua, 2016) . Superstitions and misperceptions surround the giving and receiving of blood. A lack of electronic systems makes it difficult to recall donors regularly, and to track blood units from donor to recipient. For these reasons, blood service models and interventions that work in high-income countries are unlikely to be transferable to, or appropriate for, most countries in SSA.
To address the lack of evidence from SSA to underpin their policies and practices, blood services in SSA need to conduct or commission research. Without a clear strategy to guide their research priorities, there is a risk that the scarce resources available for transfusion research will not be focused on the region's needs and may be unduly influenced by the agendas of external donors. This paper describes an inclusive and comprehensive process that identified blood transfusion research priorities in SSA, and some initial steps towards translating these research priorities into actions.
Materials and methods

Identifying transfusion research needs in SSA
The process for identifying transfusion research priorities was adapted from the consensus development method for clinical guideline development (Murphy et al, 1998) . This involves face-to-face discussions using a process that takes into account the need to: set clear tasks and questions; carefully select participants; structure interactions; and synthesise individual judgements. A two-day workshop was convened in Pretoria, South Africa for 35 participants (Appendix 1). From our experience of a previous similar workshop, this is a sufficient number to ensure that individual opinions are unlikely to have undue influence on decisions, and any bias was further reduced by incorporating a voting system (see later). Participants had long-standing track records of conducting, promoting or using research in SSA and included blood service directors, researchers, clinicians, funders, policy makers, commercial organisations and non-governmental organisations. To enhance the credibility and widespread acceptance of the outcomes, the participants were selected for their diverse perspectives, experiences and geographical location, and reflected the full range of key characteristics of the population that would need to engage with the new research priorities (Murphy et al, 1998) .
The first meeting to identify transfusion research priorities had been held in Mombasa in 2008 and had been attended by several of the same participants (Mapako et al, 2008) . At that meeting participants had grouped research topics under five themes -biological safety; blood donors; hospital use of blood; supply and distribution; and systems and financing. For the Pretoria workshop, participants were divided into five groups of 6-8 people to maximise heterogeneity of expertise and geographical location because the goal was to explore areas of uncertainty (Murphy et al, 1998) . All groups considered each of the five research themes, and the topics within that theme, in turn. They decided if these topics were still relevant. They judged whether there were any new research topics needed and if there were additional topics that did not fall within one of the five themes.
After discussing a theme, each group presented a summary of their discussions to all participants. Through plenary discussions, the research topics and specific research questions associated with each research topic were refined and agreed. These discussions produced a long list of 5-10 research questions for each theme but no indication of priority. A cumulative voting system was used to provide an indication of which research questions participants felt were most important within each theme. The research questions were written on a flip chart and each participant was provided with three sticky notes, or votes, for each topic. Each participant was asked to use all 3 of their votes and could allocate between 1 and 3 votes to those research questions they considered a priority. Through this process an indication of the distribution of participants' judgements, rather than just a 'central tendency', could be documented (Murphy et al, 1998) .
Promoting research priorities and uptake of research results
Workshop participants brainstormed a list of funders who may be interested in supporting blood services research. They also considered ways of creating a community of transfusion researchers in SSA and reducing their isolation by enhancing their research networks. One of the most challenging aspects of research is to ensure that the results are disseminated and used to influence practice and policies so a session was devoted exploring communication channels and to agreeing actions to be taken by the participants to keep up the momentum behind blood services research in SSA. Specific short and medium term actions were agreed and progress on these in the year since the workshop was followed up through meetings or using emails and Skype/telephone calls.
Results
Research themes and topics for SSA blood services
For each of the five themes, the research questions that emerged as the top five priorities are presented in Tables I-V with a synopsis of participants' justification for each topic given in the text. Topics introduced since 2008 (Hassall & Bates, 2015) are indicated. The percentage of votes for these priorities compared to the total number of votes cast for the whole theme provide an indication of the extent of agreement between participants about the importance of the five priority topics. The total votes do not represent all votes cast for the theme since some votes were for research questions that were not ranked in the top five priorities.
Justifications for topics covered by research questions regarding biological safety (Table I) .
Transfusion-relevant outbreaks: the Ebola outbreak in west Africa posed a major challenge for the blood services, particularly in terms of lack of knowledge, expertise and systems for handing highly infectious samples, and for recruiting survivors and producing convalescent plasma Infection screening: Over the last few years the major knowledge gaps in infection screening have shifted towards systems to support better testing rather than focusing on the screening tests themselves. Research topics therefore included comparative evaluations of combined testing kits, of pre-versus post-donation testing strategies, and mechanisms for establishing quality assurance systems across the different health service tiers Malaria: The burden and impact of malaria in the blood supply in SSA is poorly understood. There is no 'gold standard' test for screening donor blood. More evidence is needed about the infection risk to recipients and the likelihood of semi-immune recipients developing malaria from a transfusion. Estimates are needed about how rejection of malaria-positive donors may exacerbate blood shortages, and evidence is needed so policies can be adapted to account for differing malaria endemicities Bacterial contamination: This was considered to be under-reported and under-recognised. More data are needed to establish the prevalence, causes and clinical significance of bacterial contamination, along with evaluations of interventions to minimise risks to recipients. Hepatitis B virus (HBV) vaccination: Investigations into the impact of HBV vaccination on HBV prevalence in younger blood donors and the potential impact on blood screening strategies are needed (new).
Justifications for topics covered by research questions regarding blood donors and blood donation (Table II) .
Motivating and retaining donors. It is important to gain a better understanding of how to tailor motivational messages and recall mechanisms [e.g. Short Message Service (SMS), social media, phone calls] for the different types of blood donors (e.g. school children versus adults; first-time versus repeat donors). Innovative mechanisms to promote blood donation, such as social media, peer-motivators and incorporating blood transfusion information in school curricula need evaluating (new). Better knowledge about deterrents to becoming a first time donor, factors which contribute to donor attrition, including during the transition period after leaving school, and the role of parental consent (new). Types of blood donors. Participants recognised the need for a more nuanced understanding of the difficulties in clearly Justifications for topics covered by research questions regarding hospital management of blood and blood transfusions (Table III) .
Haemovigilance systems are almost non-existent in SSA but are an important mechanism for improving blood and patient safety. In SSA, where resources are limited and reporting systems are weak, it may not be feasible to establish and sustain a comprehensive haemovigilance system so evidence is needed to guide targeting of resources towards priorities. Alloimmunisation, iron overload and post-transfusion follow-up for transfusion-transmitted infection, particularly in patients receiving multiple transfusions such as those with sickle cell disease, are particularly under-researched in SSA Patients' costs: Transfusion may be associated with explicit and hidden costs for patients but the cost and impact on patients and their families, and on clinical decisions, are unknown Clinical use of blood: Blood is often prescribed inappropriately but the extent and reasons for this are not known. Guidelines for clinical use of blood exist but the extent of their implementation is not known. These issues often fall under the remit of hospital transfusion committees but these committees are not common in African hospitals. There is a need for these guidelines to be tailored for use in SSA and based on evidence about the use of blood and ancillary treatments, for conditions prevalent in SSA. The usefulness of different haemoglobin 'triggers' for initiating transfusion and the role of bedside haemoglobin measurements need to be explored.
Justifications for topics covered by research questions regarding adequate supplies and equitable distribution (Table IV) .
Blood donation targets: National targets for blood collection need re-evaluating using up-to-date data. The targets should be tailored for SSA and match specific needs (e.g. to account for malaria burden). An estimate of unmet Justifications for topics covered by research questions regarding transfusion systems and sustainable financing (Table IV) .
Costs and service delivery models: The costs of the individual components of the donor to recipient 'vein-tovein' process need to be measured for different service delivery models (e.g. centralised, hospital-based and hybrid systems). The applicability and replicability of various costing models needs to be assessed from the perspectives of the blood service providers, and the donors, recipients and their families.
Income generation: Ways of mitigating the risk of blood services' dependence on donor funds need to be explored, and innovative sustainable financing mechanisms, such as cost recovery, tax levies and commercial sector partnerships, tested and evaluated (new). Regulation of blood services: Blood is categorised as an 'essential medicine' so blood services in SSA are increasingly subject to new regulations. These are likely to impact on many aspects of delivery and financing of blood services. Regulation of blood services is a new role for regulators in Africa, so research is needed to define the skills the regulators will need and how their role can be used to improve, and not overburden, the blood services (new). Blood service responsiveness: The recent Ebola outbreak highlighted that blood service systems in SSA urgently need strengthening so that they can respond rapidly to changing needs. More evidence is needed about how to do this effectively in different contexts and the risks and benefits of various models. Better definitions and descriptions of blood service systems, models and structures will facilitate standard-setting, sharing of best practice among blood services and consensus on common 'leading' indicators which will enable within and between country comparisons. Purchasing power: Potential for national or regional bulk purchasing should be investigated to improve cost-effectiveness and minimise the cost per unit of blood while ensuring that blood services are financially sustainable (new). Attracting and retaining staff: More evidence is needed about the poorly understood factors affecting attraction, motivation, retention and professional development, of blood services staff in SSA and how to formalise their career progression opportunities, as this will impact on several aspects of the blood services, including costs and sustainability (new).
Promoting research priorities and uptake of research results
Financial resources to support blood services research in SSA.
Participants identified a range of funders with a reputation for supporting programmes of direct or indirect relevance to blood services. These included multi-national agencies (e.g. Global Fund, European Union, Red Cross/Crescent, World Bank), national governments and research agencies (e.g. UK, USA, France, Japan), foundations and trusts (e.g. Wellcome Trust, Bill and Melinda Gates Foundation, Rockefeller), international blood transfusion societies, universities, commercial and insurance companies, international charities (e.g. Lions, Rotary) and vertical programmes concerned with maternal and neonatal health, HIV and malaria. What sustainable cost-recovery models already exist in SSA and how can they be adopted in other countries?
22
What has been the impact on, and sustainability of, blood safety programmes of external financial donor input (and withdrawal)?
17
How can blood services transition from external donor funding (e.g. PEPFAR) to 'internal' (local) funding?
12
How can the cost of production of blood units be minimised to ensure sustainability?
8 Can a dynamic model be developed to determine a vein-to-vein cost (using established models for HIV/maternal health) of a blood transfusion? Strengthening research skills and communities. Several innovative approaches were proposed for increasing the number of researchers and volume of blood services research in SSA. These included blood services hosting PhD students registered at local universities, promoting more in-service research by blood service staff, advertising blood service projects for MSc and BSc students, and ensuring that blood service issues were covered in the curricula of schools and universities. Ideas for incentives that could be used to motivate blood service staff to undertake research included education grants for courses to learn research skills, funding conference and workshop attendance, recognising research activities for promotion, including research experience as a recruitment criterion, public recognition of individuals' research contributions through ceremonies and newsletters, support for new researchers to develop proposals, and creating a research-conducive environment within the blood services.
Participants recognised the importance of research for keeping up-to-date with technology and best practice, and for problem solving to make blood services more efficient. However, their main priority is to provide blood for their nation's population and they were therefore not able to invest a substantial proportion of their scarce resources in research. A potential solution that emerged from discussions was to create formal links with academic institutions. Proposed mechanisms to achieve this included obtaining appropriate ethical and regulatory approvals for researchers to use blood service resources (e.g. samples, donor data, test results) to attract university researchers to work with the blood service in exchange for blood service staff teaching in the universities. Some blood services may also be able to host a research office and act as a resource for research information.
Research uptake. Uptake of research evidence to improve services is notoriously difficult so participants made practical suggestions about how this might be achieved in the context of blood services in SSA. Participants understood that to promote research uptake at national and international level and influence changes to guidelines it was important to understand the needs of the policy makers and regulators and to involve them at all stages of the research process. There are already a small number of blood transfusion research networks in SSA, such as the Francophone Africa Research Network and T-REC networks (Tagny et al, 2014; Bates, 2016) , that have some capacity to act as dissemination channels and foci for research activities. Participants suggested other mechanisms for promoting research uptake including through scientific publications and through presentations at, for example, grand rounds, journal clubs and scientific research meetings. Opportunities for promoting more use of evidence within individual blood services included sharing research results with clinical collaborators, providing training for blood service decision makers in how to critically review evidence, establishing internal mechanisms for commissioning research, reviewing results and instigating evidence-based change.
Short and medium term actions. Several activities were undertaken by workshop participants in the year following the workshop to promote the research priorities and enhance research capacity in blood services research in SSA. The research priorities have been disseminated through presentations at international meetings and through the websites of the International and African Societies for Blood Transfusion and the European Union. Research related to blood transfusion in SSA and published in the last 7 years has been identified and analysed. This is being summarised for publication and includes information on the topics researched and their frequency, as well as an analysis of the researchers and collaborators, and institutions and countries involved. A database of individuals involved in blood services research has been established and is hosted and maintained by the International Society for Blood Transfusion (ISBT) (2016). We are aware of three grants applications that have been submitted for funding, together with several student projects and publications that all focus on priorities identified at the workshop. Assessments of research capacity within blood services in Ghana and Zimbabwe (Mapako et al, 2016) 
Discussion
This study provides a comprehensive list of research topics and questions that multi-disciplinary blood services stakeholders across SSA have identified as their most pressing needs. Information is provided about each topic to help those doing and commissioning research to appreciate the rationale behind each topic. Many of the priorities focus on traditionally common research areas, such as clinical use of blood and infection screening, but there is clearly a move away from the HIV research that predominated over the last two decades. Included in the list are some new and exciting research topics, such as the impact of HBV vaccination on screening strategies, culturally sensitive donor motivation messages using social media and messaging, and novel approaches to income generation.
It is striking that many of the major knowledge gaps concern blood service 'systems' such as economic costs including from the perspectives of patients and their families; blood component need, production and use, and blood service regulation. Weak systems severely limit the ability of blood services in SSA to respond to challenges, such as the Ebola epidemic, to address shortfalls in supply and to keep pace with new developments including growing demand for blood products for cancer care and trauma (Dzik, 2015; WHO, 2015b) . Blood services research in SSA is severely hampered by the lack of robust data concerning, for example, haemovigilance, donor recall and blood tracking. Widespread reliance on manual records means that blood services in SSA do not have data about their activities and cannot demonstrate their contribution to population health or make a business case for investment. Recent efforts to introduce electronic blood service information systems in SSA should help address these issues and provide a better platform for research (https://www.jembi.org/project/blood-safety-informa tion-system/).
During the workshop many examples of known effective interventions were identified which are not reaching the people or services that could benefit from them. Research into how to implement evidence-based interventions is therefore needed to understand how to deploy and scale up these interventions in different contexts and to overcome health system barriers to the delivery of policies or programmes (Hales et al, 2016) . Implementation research should be problem-focused, action-oriented and aligned with the needs of blood services and health systems. This type of research draws on multiple disciplines and is a collaborative endeavour requiring the engagement of a wide range of stakeholders, including researchers, policy makers, opinion leaders, and private and public sectors (Peters et al, 2013) .
The audience for these research priorities is diverse. In addition to blood service staff and managers in SSA, it includes researchers, consumers of blood transfusion research (such as policy makers, clinicians and hospital managers), research and development funders, journal editors and conference organisers. For researchers, the list of priority topics and associated justification will help them frame their research applications and projects so that they can provide precise answers to fill the knowledge gaps. Having a list of research priorities will raise awareness of the key issues among users of research so that they can create mechanisms to promote demand for specific research and to rapidly utilise the results. Organisations that fund health research and development can focus their grant opportunities and selection processes to ensure that the neglected research areas in blood services are targeted for funding. Agencies that provide a forum for disseminating research, such as academic journal editors and conference organisers, can provide space to highlight outputs that specifically relate to the research priorities.
A key finding of the Mombasa meeting in 2008 had been that there was extremely limited transfusion research expertise in SSA, both within blood services and in the wider research community. This meant that there were almost no individuals or institutions in SSA that could address the research gaps identified by participants. Some early steps have been taken to enhance the visibility of blood transfusion research in SSA, to disseminate the research priorities and to re-orientate research efforts towards these priorities. Since 2008 the African Society for Blood Transfusion in collaboration with the European Union-funded T-REC programme to enhance transfusion research skills in SSA, has organised several workshops and research training initiatives. These efforts have increased research capacity in SSA's blood services and raised awareness among diverse stakeholders within and beyond SSA about the importance of blood transfusion research in Africa. However much more needs to be done to ensure that blood services in SSA can generate and use locally-appropriate evidence to develop, implement and update guidelines in response to their constantly changing environment. Although blood services in SSA should drive and own the research process, partnerships with other African and international development communities were recognised to be essential for sharing and keeping abreast of the latest developments. Until the essential role of research in problem solving and challenging the status quo is addressed, the many needless deaths due to blood shortages in SSA will continue.
